SSTR3 and neoplasm: If a different SSTR3 expression based on sex holds true also for other PT cell types, these results could have broader clinical relevance given that pasireotide is currently recommended for the treatment of patients with Cushing’s disease in whom surgery was unsuccessful, and of acromegalic patients who remain uncontrolled after surgery or in whom tumor resection is not possible.